Fundraising Fox

Aglaia Oncology Funds

5 known investors

Find your way into Aglaia Oncology Funds

Aglaia is an investment firm specializing in early-stage oncology drug development companies, selecting and maturing breakthrough inventions with potential to transform cancer treatment. The firm has invested in 12 early-stage companies since 2004, six of which it founded, and has been involved in developing over 100 oncology products.

BiotechDeep Tech

Investors · 5

BOMTilburg · $540K – $5.4M
Aurora SciencereportedMilano
Cathay VenturereportedTaipei · $4M – $38M
KorysreportedHalle · $5.4M
Oost NLreportedApeldoorn · $108K – $5.4M

In the news

Aglaia Oncology Funds - Golden Egg Checkgoldeneggcheck.com · Mar 2022Sapreme Boosts Development of its Endosomal Escape Technology Platform and Proprietary Pipeline with EUR 15M Series Abusinesswire.com · Oct 2021OostNL backs the €18.5M Series B funding round of this Dutch biotech company that’s fighting cancer - Silicon Canalssiliconcanals.com · Feb 2021InteRNA Technologies Extends Series B Financing Round Totaling €18.5Mfinsmes.com · Feb 2021MIMETAS Secures 20 Million Dollar Series B Financing | Aglaia Oncology Fundsaglaia-oncology.com · Apr 2018Karl Rothweiler | Aglaia Oncology Fundsaglaia-oncology.com

Frequently asked questions

What does Aglaia Oncology Funds do?
Aglaia is an investment firm specializing in early-stage oncology drug development companies, selecting and maturing breakthrough inventions with potential to transform cancer treatment. The firm has invested in 12 early-stage companies since 2004, six of which it founded, and has been involved in developing over 100 oncology products.
Who are Aglaia Oncology Funds's investors?
Aglaia Oncology Funds's investors include BOM, Aurora Science, Cathay Venture, Korys, Oost NL.